Danaher Diagnostics — Sales increased by 10.4% to $2.72B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $2.64B to $2.72B. Over 2 years (FY 2023 to FY 2025), Diagnostics — Sales shows relatively stable performance with a 1.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or demand for diagnostic products, while a decrease may signal competitive pressure or market saturation.
Represents the total revenue generated from the sale of diagnostic products, instruments, and related consumables within...
Standard revenue metric reported by all life science and healthcare peers.
dhr_segment_diagnostics_sales| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.34B | $2.45B | $2.64B | $2.56B | $2.68B | $2.38B | $2.23B | $2.25B | $2.72B | $2.53B | $2.26B | $2.36B | $2.64B | $2.45B | $2.31B | $2.46B | $2.72B |
| QoQ Change | — | +4.8% | +8.0% | -3.1% | +4.6% | -11.3% | -6.1% | +1.0% | +20.5% | -7.0% | -10.6% | +4.6% | +11.6% | -7.1% | -5.7% | +6.7% | +10.4% |
| YoY Change | — | — | — | +9.6% | +9.4% | -10.1% | -12.9% | -15.9% | — | +6.4% | +1.3% | +4.8% | -2.9% | -3.1% | +2.2% | +4.2% | +3.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.